SCHEMBL2823891

SCHEMBL2823891

COCCC#Cc1ccccc1C(=O)C(=O)c1ccc(OC(F)F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.43
▸ BACE1 P56817 2/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ GFER P55789 1/20 0.39
▸ ADAM17 P78536 1/20 0.39
▸ REN P00797 1/20 0.39
▸ CTSD P07339 1/20 0.39
▸ BACE2 Q9Y5Z0 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ ATM Q13315 1/20 0.38
▸ HTT P42858 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ LMNA P02545 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2820748 0.87 ALDH1A1 (0.43) ALDH1A1BACE1ALOX15GFERADAM17
SCHEMBL2822173 0.85 ALDH1A1 (0.44) ALDH1A1ALOX15GFERADAM17PKM
SCHEMBL2823197 0.85 ALDH1A1 (0.44) ALDH1A1ALOX15GFERADAM17PKM
SCHEMBL2795168 0.81 BACE1 (0.52) ALDH1A1BACE1ALOX15GFERADAM17
SCHEMBL2793343 0.73 ALDH1A1 (0.48) ALDH1A1ALOX15GFERADAM17PKM
SCHEMBL2823925 0.71 ALDH1A1 (0.48) ALDH1A1BACE1ALOX15GFERADAM17
SCHEMBL2796489 0.70 BACE1 (0.42) ALDH1A1BACE1ALOX15GFERADAM17
SCHEMBL2792367 0.70 CES2 (0.58) ALDH1A1ALOX15GFERADAM17PKM
SCHEMBL2791684 0.70 ALOX15 (0.66) ALDH1A1ALOX15GFERADAM17PKM
SCHEMBL4312229 0.69 PKM (0.43) ALDH1A1ALOX15GFERADAM17PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100168194-A1 Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone Compounds For The Inhibition Of Beta-secretase WYETH LLC (US) 2010-07-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168194-A1 Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone Compounds For The Inhibition Of Beta-secretase BACE1, BACE2, APP ALDH1A1 3041/4885BACE1 1/4885ALOX15 3444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback